BMS-753426 is a potent and orally bioavailable antagonist of CCR2. Compared to previous clinical candidate BMS-741672, BMS-753426 showed significant improvements in pharmacokinetic properties, with lower clearance and higher oral bioavailability. Furthermore, BMS-753426 exhibited improved affinity for CCR5 and good activity in models of both monocyte migration and multiple sclerosis in the hCCR2 knock-in mouse.
MedKoo Cat#: 464774
Name: BMS-753426
CAS#: 1004536-52-0
Chemical Formula: C25H33F3N6O2
Exact Mass: 506.2617
Molecular Weight: 506.57
Elemental Analysis: C, 59.28; H, 6.57; F, 11.25; N, 16.59; O, 6.32
The following data is based on the product molecular weight 506.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |